Literature DB >> 26501435

miR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells.

Zhongxue Ye1, Le Zhao, Jie Li, Wei Chen, Xu Li.   

Abstract

OBJECTIVE: MicroRNAs (miRs) are essential regulators of gene expression by suppressing translation or causing degradation of target mRNA. Growing evidence sheds light on the crucial roles of miR dysregulation in cancer development and progression. In this study, we focused on the role of miR-30d in transforming growth factor β1 (TGF-β1)-initiated epithelial-mesenchymal transition (EMT) in ovarian cancer cells.
METHODS: Transforming growth factor β1 (10 ng/mL) was used to initiate EMT in SKOV3 and 3AO cells. The expression of miR-30 family members was determined by quantitative real-time polymerase chain reaction. Messenger RNA and protein levels of E-cadherin, N-cadherin, vimentin, and Snail were detected by quantitative real-time polymerase chain reaction and Western blot, respectively. Cell migration and invasion capacities were evaluated by Transwell chamber assay. Luciferase activity assay was performed to verify the direct inhibition of Snail by miR-30d.
RESULTS: MiR-30b, MiR-30c, and MiR-30d were down-regulated during TGF-β1-induced EMT in SKOV3 and 3AO ovarian cancer cells. Restoration of miR-30d by miR-30d mimic reversed TGF-β1-induced EMT phenotypes including the morphological changes, expression pattern of molecular markers (E-cadherin, N-cadherin), and migratory and invasive capabilities in ovarian cancer cells. Furthermore, Snail was identified as the direct target of miR-30d.
CONCLUSIONS: Our results revealed that miR-30d functioned as a suppressor of ovarian cancer progression by decreasing Snail expression and thus blocking TGF-β1-induced EMT process, suggesting the potentiality of miR-30d analogs to be used as therapeutics for ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26501435     DOI: 10.1097/IGC.0000000000000546

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  27 in total

Review 1.  Targeting IGF1R pathway in cancer with microRNAs: How close are we?

Authors:  Arathy S Kumar; Suresh K Rayala; Ganesh Venkatraman
Journal:  RNA Biol       Date:  2018-02-01       Impact factor: 4.652

2.  Differentiation in stem/progenitor cells along fetal or adult hepatic stages requires transcriptional regulators independently of oscillations in microRNA expression.

Authors:  Sriram Bandi; Sanchit Gupta; Tatyana Tchaikovskaya; Sanjeev Gupta
Journal:  Exp Cell Res       Date:  2018-06-06       Impact factor: 3.905

3.  miRNA-199a-5p suppresses proliferation and invasion by directly targeting NF-κB1 in human ovarian cancer cells.

Authors:  Xiaoxiao Liu; Baofeng Yao; Zhiming Wu
Journal:  Oncol Lett       Date:  2018-07-18       Impact factor: 2.967

4.  Immune regulation of miR-30 on the Mycobacterium tuberculosis-induced TLR/MyD88 signaling pathway in THP-1 cells.

Authors:  Yuqing Wu; Qi Sun; Liang Dai
Journal:  Exp Ther Med       Date:  2017-08-02       Impact factor: 2.447

5.  Transcriptional and posttranscriptional regulation of HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in esophageal squamous carcinoma cells.

Authors:  C Lin; Y Wang; Y Wang; S Zhang; L Yu; C Guo; H Xu
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

6.  Engagement of circular RNA HECW2 in the nonautophagic role of ATG5 implicated in the endothelial-mesenchymal transition.

Authors:  Li Yang; Bing Han; Yuan Zhang; Ying Bai; Jie Chao; Gang Hu; Honghong Yao
Journal:  Autophagy       Date:  2018-01-29       Impact factor: 16.016

Review 7.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

8.  MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway.

Authors:  Zhao Xiaohong; Fan Lichun; Xie Na; Zou Kejian; Xiao Xiaolan; Wang Shaosheng
Journal:  Tumour Biol       Date:  2016-09-21

9.  TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells.

Authors:  Zhongxue Ye; Jie Li; Xi Han; Huilian Hou; He Chen; Xia Zheng; Jiaojiao Lu; Lijie Wang; Wei Chen; Xu Li; Le Zhao
Journal:  J Exp Clin Cancer Res       Date:  2016-05-04

Review 10.  New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.

Authors:  Erika Larrea; Carla Sole; Lorea Manterola; Ibai Goicoechea; María Armesto; María Arestin; María M Caffarel; Angela M Araujo; María Araiz; Marta Fernandez-Mercado; Charles H Lawrie
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.